APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non-Clinical CRO Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non-Clinical CRO Services Market Analysis and Forecast 2026-2032

1 May 2026207 pages

Choose your research edition.

Industry ResearchNon-Clinical CRO Services Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Non-Clinical CRO Services Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Non-Clinical CRO Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non-Clinical CRO Services Market Outlook and Growth Opportunities 2026181 pages · $4,250 USDMarket Analysis & ForecastGlobal Non-Clinical CRO Services Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Non-Clinical CRO Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Non-Clinical CRO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non-Clinical CRO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non-Clinical CRO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non-Clinical CRO Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Non-Clinical CRO Services include CMIC Group, Shanghai Innostar Biotech, ApconiX, Charles River Laboratories, ERBC Group, STILLMEADOW and ICON, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Non-Clinical CRO Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non-Clinical CRO Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Non-Clinical CRO Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-Clinical CRO Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non-Clinical CRO Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Non-Clinical CRO Services revenue, projected growth trends, production technology, application and end-user industry.

Non-Clinical CRO Services Segment by Company

CMIC Group

Shanghai Innostar Biotech

ApconiX

Charles River Laboratories

ERBC Group

STILLMEADOW

ICON

Non-Clinical CRO Services Segment by Type

Safety Pharmacology Testing

Administration Toxicity Test

Reproductive Toxicity Test

Genotoxicity Test

Immunogenicity Studies

Carcinogenicity Test

Other

Non-Clinical CRO Services Segment by Application

Pharmaceutical Center

Institute

Hospital

Non-Clinical CRO Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non-Clinical CRO Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non-Clinical CRO Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non-Clinical CRO Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Non-Clinical CRO Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Non-Clinical CRO Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Clinical CRO Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non-Clinical CRO Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Safety Pharmacology Testing Major Player Table 3. Administration Toxicity Test Major Player Table 4. Reproductive Toxicity Test Major Player Table 5. Genotoxicity Test Major Player Table 6. Immunogenicity Studies Major Player Table 7. Carcinogenicity Test Major Player Table 8. Other Major Player Table 9. Global Non-Clinical CRO Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Pharmaceutical Center Major Player Table 11. Institute Major Player Table 12. Hospital Major Player Table 13. Non-Clinical CRO Services Industry Trends Table 14. Non-Clinical CRO Services Industry Drivers Table 15. Non-Clinical CRO Services Industry Opportunities and Challenges Table 16. Non-Clinical CRO Services Industry Restraints Table 17. Global Non-Clinical CRO Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 18. Global Non-Clinical CRO Services Market Size by Region (2021-2026) & (US$ Million) Table 19. Global Non-Clinical CRO Services Market Share by Region (2021-2026) Table 20. Global Non-Clinical CRO Services Market Size by Region (2027-2032) & (US$ Million) Table 21. Global Non-Clinical CRO Services Market Share by Region (2027-2032) Table 22. Global Non-Clinical CRO Services Revenue by Players (US$ Million) & (2021-2026) Table 23. Global Non-Clinical CRO Services Revenue Market Share by Players (2021-2026) Table 24. Global Non-Clinical CRO Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Non-Clinical CRO Services Key Players Headquarters & Area Served Table 26. Global Non-Clinical CRO Services Players, Product Type & Application Table 27. Global Non-Clinical CRO Services Players Establishment Date Table 28. Global Players Market Concentration Ratio (CR5 and HHI) Table 29. Global Non-Clinical CRO Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 30. Global Non-Clinical CRO Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Non-Clinical CRO Services Revenue by Type (2021-2026) & (US$ Million) Table 32. Global Non-Clinical CRO Services Revenue by Type (2027-2032) & (US$ Million) Table 33. Global Non-Clinical CRO Services Revenue Market Share by Type (2021-2026) Table 34. Global Non-Clinical CRO Services Revenue Market Share by Type (2027-2032) Table 35. Global Non-Clinical CRO Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Non-Clinical CRO Services Revenue by Application (2021-2026) & (US$ Million) Table 37. Global Non-Clinical CRO Services Revenue by Application (2027-2032) & (US$ Million) Table 38. Global Non-Clinical CRO Services Revenue Market Share by Application (2021-2026) Table 39. Global Non-Clinical CRO Services Revenue Market Share by Application (2027-2032) Table 40. CMIC Group Company Information Table 41. CMIC Group Business Overview Table 42. CMIC Group Non-Clinical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. CMIC Group Non-Clinical CRO Services Product Portfolio Table 44. CMIC Group Recent Development Table 45. Shanghai Innostar Biotech Company Information Table 46. Shanghai Innostar Biotech Business Overview Table 47. Shanghai Innostar Biotech Non-Clinical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Shanghai Innostar Biotech Non-Clinical CRO Services Product Portfolio Table 49. Shanghai Innostar Biotech Recent Development Table 50. ApconiX Company Information Table 51. ApconiX Business Overview Table 52. ApconiX Non-Clinical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. ApconiX Non-Clinical CRO Services Product Portfolio Table 54. ApconiX Recent Development Table 55. Charles River Laboratories Company Information Table 56. Charles River Laboratories Business Overview Table 57. Charles River Laboratories Non-Clinical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Charles River Laboratories Non-Clinical CRO Services Product Portfolio Table 59. Charles River Laboratories Recent Development Table 60. ERBC Group Company Information Table 61. ERBC Group Business Overview Table 62. ERBC Group Non-Clinical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ERBC Group Non-Clinical CRO Services Product Portfolio Table 64. ERBC Group Recent Development Table 65. STILLMEADOW Company Information Table 66. STILLMEADOW Business Overview Table 67. STILLMEADOW Non-Clinical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. STILLMEADOW Non-Clinical CRO Services Product Portfolio Table 69. STILLMEADOW Recent Development Table 70. ICON Company Information Table 71. ICON Business Overview Table 72. ICON Non-Clinical CRO Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. ICON Non-Clinical CRO Services Product Portfolio Table 74. ICON Recent Development Table 75. North America Non-Clinical CRO Services Revenue by Type (2021-2026) & (US$ Million) Table 76. North America Non-Clinical CRO Services Revenue by Type (2027-2032) & (US$ Million) Table 77. North America Non-Clinical CRO Services Revenue by Application (2021-2026) & (US$ Million) Table 78. North America Non-Clinical CRO Services Revenue by Application (2027-2032) & (US$ Million) Table 79. North America Non-Clinical CRO Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Non-Clinical CRO Services Revenue by Country (2021-2026) & (US$ Million) Table 81. North America Non-Clinical CRO Services Revenue by Country (US$ Million) & (2027-2032) Table 82. Europe Non-Clinical CRO Services Revenue by Type (2021-2026) & (US$ Million) Table 83. Europe Non-Clinical CRO Services Revenue by Type (2027-2032) & (US$ Million) Table 84. Europe Non-Clinical CRO Services Revenue by Application (2021-2026) & (US$ Million) Table 85. Europe Non-Clinical CRO Services Revenue by Application (2027-2032) & (US$ Million) Table 86. Europe Non-Clinical CRO Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 87. Europe Non-Clinical CRO Services Revenue by Country (2021-2026) & (US$ Million) Table 88. Europe Non-Clinical CRO Services Revenue by Country (US$ Million) & (2027-2032) Table 89. China Non-Clinical CRO Services Revenue by Type (2021-2026) & (US$ Million) Table 90. China Non-Clinical CRO Services Revenue by Type (2027-2032) & (US$ Million) Table 91. China Non-Clinical CRO Services Revenue by Application (2021-2026) & (US$ Million) Table 92. China Non-Clinical CRO Services Revenue by Application (2027-2032) & (US$ Million) Table 93. Asia Non-Clinical CRO Services Revenue by Type (2021-2026) & (US$ Million) Table 94. Asia Non-Clinical CRO Services Revenue by Type (2027-2032) & (US$ Million) Table 95. Asia Non-Clinical CRO Services Revenue by Application (2021-2026) & (US$ Million) Table 96. Asia Non-Clinical CRO Services Revenue by Application (2027-2032) & (US$ Million) Table 97. Asia Non-Clinical CRO Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Asia Non-Clinical CRO Services Revenue by Region (US$ Million) & (2021-2026) Table 99. Asia Non-Clinical CRO Services Revenue by Region (US$ Million) & (2027-2032) Table 100. SAMEA Non-Clinical CRO Services Revenue by Type (2021-2026) & (US$ Million) Table 101. SAMEA Non-Clinical CRO Services Revenue by Type (2027-2032) & (US$ Million) Table 102. SAMEA Non-Clinical CRO Services Revenue by Application (2021-2026) & (US$ Million) Table 103. SAMEA Non-Clinical CRO Services Revenue by Application (2027-2032) & (US$ Million) Table 104. SAMEA Non-Clinical CRO Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. SAMEA Non-Clinical CRO Services Revenue by Country (2021-2026) & (US$ Million) Table 106. SAMEA Non-Clinical CRO Services Revenue by Country (US$ Million) & (2027-2032) Table 107. Research Programs/Design for This Report Table 108. Authors List of This Report Table 109. Secondary Sources Table 110. Primary Sources List of Figures Figure 1. Non-Clinical CRO Services Image Figure 2. Global Non-Clinical CRO Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non-Clinical CRO Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Safety Pharmacology Testing Image Figure 5. Administration Toxicity Test Image Figure 6. Reproductive Toxicity Test Image Figure 7. Genotoxicity Test Image Figure 8. Immunogenicity Studies Image Figure 9. Carcinogenicity Test Image Figure 10. Other Image Figure 11. Global Non-Clinical CRO Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Non-Clinical CRO Services Market Size Share 2021 VS 2025 VS 2032 Figure 13. Pharmaceutical Center Image Figure 14. Institute Image Figure 15. Hospital Image Figure 16. Global Non-Clinical CRO Services Market Size (US$ Million) & (2021-2032) Figure 17. Global Non-Clinical CRO Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Non-Clinical CRO Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 19. Global Non-Clinical CRO Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Non-Clinical CRO Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Non-Clinical CRO Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Non-Clinical CRO Services Revenue Market Share by Type (2021-2032) Figure 24. Global Non-Clinical CRO Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Non-Clinical CRO Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 26. Global Non-Clinical CRO Services Revenue Market Share by Application (2021-2032) Figure 27. North America Non-Clinical CRO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 28. North America Non-Clinical CRO Services Revenue Share by Type (2021-2032) Figure 29. North America Non-Clinical CRO Services Revenue Share by Application (2021-2032) Figure 30. North America Non-Clinical CRO Services Revenue Share by Country (2021-2032) Figure 31. United States Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Canada Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Mexico Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. Europe Non-Clinical CRO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 35. Europe Non-Clinical CRO Services Revenue Share by Type (2021-2032) Figure 36. Europe Non-Clinical CRO Services Revenue Share by Application (2021-2032) Figure 37. Europe Non-Clinical CRO Services Revenue Share by Country (2021-2032) Figure 38. Germany Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. France Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. U.K. Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Italy Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Spain Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Russia Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Netherlands Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. Nordic Countries Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 46. China Non-Clinical CRO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. China Non-Clinical CRO Services Revenue Share by Type (2021-2032) Figure 48. China Non-Clinical CRO Services Revenue Share by Application (2021-2032) Figure 49. Asia Non-Clinical CRO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 50. Asia Non-Clinical CRO Services Revenue Share by Type (2021-2032) Figure 51. Asia Non-Clinical CRO Services Revenue Share by Application (2021-2032) Figure 52. Asia Non-Clinical CRO Services Revenue Share by Region (2021-2032) Figure 53. Japan Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. South Korea Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. India Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Australia Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Taiwan Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Southeast Asia Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. SAMEA Non-Clinical CRO Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 60. SAMEA Non-Clinical CRO Services Revenue Share by Type (2021-2032) Figure 61. SAMEA Non-Clinical CRO Services Revenue Share by Application (2021-2032) Figure 62. SAMEA Non-Clinical CRO Services Revenue Share by Country (2021-2032) Figure 63. Brazil Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Argentina Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Chile Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Colombia Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Peru Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Saudi Arabia Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Israel Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. UAE Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Turkey Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Iran Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Egypt Non-Clinical CRO Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Safety Pharmacology Testing
  • Administration Toxicity Test
  • Reproductive Toxicity Test
  • Genotoxicity Test
  • Immunogenicity Studies
  • Carcinogenicity Test
  • Other
Applications
  • Pharmaceutical Center
  • Institute
  • Hospital
Companies covered
  • CMIC Group
  • Shanghai Innostar Biotech
  • ApconiX
  • Charles River Laboratories
  • ERBC Group
  • STILLMEADOW
  • ICON

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non-Clinical CRO Services Market by Type
  3. 1.2.1 Global Non-Clinical CRO Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Safety Pharmacology Testing
  5. 1.2.3 Administration Toxicity Test
  6. 1.2.4 Reproductive Toxicity Test
  7. 1.2.5 Genotoxicity Test
  8. 1.2.6 Immunogenicity Studies
  9. 1.2.7 Carcinogenicity Test
  10. 1.2.8 Other
  11. 1.3 Non-Clinical CRO Services Market by Application
  12. 1.3.1 Global Non-Clinical CRO Services Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Pharmaceutical Center
  14. 1.3.3 Institute
  15. 1.3.4 Hospital
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Non-Clinical CRO Services Market Dynamics
  1. 2.1 Non-Clinical CRO Services Industry Trends
  2. 2.2 Non-Clinical CRO Services Industry Drivers
  3. 2.3 Non-Clinical CRO Services Industry Opportunities and Challenges
  4. 2.4 Non-Clinical CRO Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Non-Clinical CRO Services Market Perspective (2021-2032)
  2. 3.2 Global Non-Clinical CRO Services Growth Trends by Region
  3. 3.2.1 Global Non-Clinical CRO Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non-Clinical CRO Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Non-Clinical CRO Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Non-Clinical CRO Services Revenue by Players
  2. 4.1.1 Global Non-Clinical CRO Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Non-Clinical CRO Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Non-Clinical CRO Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non-Clinical CRO Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Non-Clinical CRO Services Key Players Headquarters & Area Served
  7. 4.4 Global Non-Clinical CRO Services Players, Product Type & Application
  8. 4.5 Global Non-Clinical CRO Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Non-Clinical CRO Services Market CR5 and HHI
  11. 4.6.3 2025 Non-Clinical CRO Services Tier 1, Tier 2, and Tier 3
5 Non-Clinical CRO Services Market Size by Type
  1. 5.1 Global Non-Clinical CRO Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Non-Clinical CRO Services Revenue by Type (2021-2032)
  3. 5.3 Global Non-Clinical CRO Services Revenue Market Share by Type (2021-2032)
6 Non-Clinical CRO Services Market Size by Application
  1. 6.1 Global Non-Clinical CRO Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Non-Clinical CRO Services Revenue by Application (2021-2032)
  3. 6.3 Global Non-Clinical CRO Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 CMIC Group
  2. 7.1.1 CMIC Group Company Information
  3. 7.1.2 CMIC Group Business Overview
  4. 7.1.3 CMIC Group Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 CMIC Group Non-Clinical CRO Services Product Portfolio
  6. 7.1.5 CMIC Group Recent Developments
  7. 7.2 Shanghai Innostar Biotech
  8. 7.2.1 Shanghai Innostar Biotech Company Information
  9. 7.2.2 Shanghai Innostar Biotech Business Overview
  10. 7.2.3 Shanghai Innostar Biotech Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Shanghai Innostar Biotech Non-Clinical CRO Services Product Portfolio
  12. 7.2.5 Shanghai Innostar Biotech Recent Developments
  13. 7.3 ApconiX
  14. 7.3.1 ApconiX Company Information
  15. 7.3.2 ApconiX Business Overview
  16. 7.3.3 ApconiX Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 ApconiX Non-Clinical CRO Services Product Portfolio
  18. 7.3.5 ApconiX Recent Developments
  19. 7.4 Charles River Laboratories
  20. 7.4.1 Charles River Laboratories Company Information
  21. 7.4.2 Charles River Laboratories Business Overview
  22. 7.4.3 Charles River Laboratories Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Charles River Laboratories Non-Clinical CRO Services Product Portfolio
  24. 7.4.5 Charles River Laboratories Recent Developments
  25. 7.5 ERBC Group
  26. 7.5.1 ERBC Group Company Information
  27. 7.5.2 ERBC Group Business Overview
  28. 7.5.3 ERBC Group Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 ERBC Group Non-Clinical CRO Services Product Portfolio
  30. 7.5.5 ERBC Group Recent Developments
  31. 7.6 STILLMEADOW
  32. 7.6.1 STILLMEADOW Company Information
  33. 7.6.2 STILLMEADOW Business Overview
  34. 7.6.3 STILLMEADOW Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 STILLMEADOW Non-Clinical CRO Services Product Portfolio
  36. 7.6.5 STILLMEADOW Recent Developments
  37. 7.7 ICON
  38. 7.7.1 ICON Company Information
  39. 7.7.2 ICON Business Overview
  40. 7.7.3 ICON Non-Clinical CRO Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 ICON Non-Clinical CRO Services Product Portfolio
  42. 7.7.5 ICON Recent Developments
8 North America
  1. 8.1 North America Non-Clinical CRO Services Revenue (2021-2032)
  2. 8.2 North America Non-Clinical CRO Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Non-Clinical CRO Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Non-Clinical CRO Services Revenue by Type (2027-2032)
  5. 8.3 North America Non-Clinical CRO Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Non-Clinical CRO Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Non-Clinical CRO Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Non-Clinical CRO Services Revenue by Application (2027-2032)
  9. 8.5 North America Non-Clinical CRO Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Non-Clinical CRO Services Revenue by Country
  11. 8.6.1 North America Non-Clinical CRO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Non-Clinical CRO Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Non-Clinical CRO Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Non-Clinical CRO Services Revenue (2021-2032)
  2. 9.2 Europe Non-Clinical CRO Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Non-Clinical CRO Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Non-Clinical CRO Services Revenue by Type (2027-2032)
  5. 9.3 Europe Non-Clinical CRO Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Non-Clinical CRO Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Non-Clinical CRO Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Non-Clinical CRO Services Revenue by Application (2027-2032)
  9. 9.5 Europe Non-Clinical CRO Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Non-Clinical CRO Services Revenue by Country
  11. 9.6.1 Europe Non-Clinical CRO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Non-Clinical CRO Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Non-Clinical CRO Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Non-Clinical CRO Services Revenue (2021-2032)
  2. 10.2 China Non-Clinical CRO Services Revenue by Type (2021-2032)
  3. 10.2.1 China Non-Clinical CRO Services Revenue by Type (2021-2026)
  4. 10.2.2 China Non-Clinical CRO Services Revenue by Type (2027-2032)
  5. 10.3 China Non-Clinical CRO Services Revenue Share by Type (2021-2032)
  6. 10.4 China Non-Clinical CRO Services Revenue by Application (2021-2032)
  7. 10.4.1 China Non-Clinical CRO Services Revenue by Application (2021-2026)
  8. 10.4.2 China Non-Clinical CRO Services Revenue by Application (2027-2032)
  9. 10.5 China Non-Clinical CRO Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non-Clinical CRO Services Revenue (2021-2032)
  2. 11.2 Asia Non-Clinical CRO Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Non-Clinical CRO Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Non-Clinical CRO Services Revenue by Type (2027-2032)
  5. 11.3 Asia Non-Clinical CRO Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Non-Clinical CRO Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Non-Clinical CRO Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Non-Clinical CRO Services Revenue by Application (2027-2032)
  9. 11.5 Asia Non-Clinical CRO Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Non-Clinical CRO Services Revenue by Country
  11. 11.6.1 Asia Non-Clinical CRO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Non-Clinical CRO Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Non-Clinical CRO Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non-Clinical CRO Services Revenue (2021-2032)
  2. 12.2 SAMEA Non-Clinical CRO Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Non-Clinical CRO Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Non-Clinical CRO Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Non-Clinical CRO Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Non-Clinical CRO Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Non-Clinical CRO Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Non-Clinical CRO Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Non-Clinical CRO Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Non-Clinical CRO Services Revenue by Country
  11. 12.6.1 SAMEA Non-Clinical CRO Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Non-Clinical CRO Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Non-Clinical CRO Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst